← Back
TRex Bio
TRXB · listed on Nasdaq · worth $371.07 million
$13.79
−0.58% on Oct 27
Three insider buys in the last year, $3.8 million in all. None in the last two weeks.
Green dot = an insider boughtA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
2.4M shares
9% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, two insiders bought TRex Bio stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
10% owner
Alexandria Venture Investments
Bought $2.5M on Oct 13 — 178,571 shares at $14.00, 13% of what they now own.
No earlier purchases to measure
10% owner
SVLSF VI
Bought $1.26M on Oct 8 — 89,783 shares at $14.00, held through a trust or family, 42% of what they now own.
No earlier purchases to measure
Big investors
People and funds that reported owning 5% or more of TRex Bio, newest first.
Filed by someone who owns 5% or more and may try to influence how the company is run.ELI LILLY & Co19.9%Oct 16
Filed by someone who owns 5% or more and may try to influence how the company is run.SV Biotech Crossover Opportunities Fund LP7.0%Oct 16
Filed by someone who owns 5% or more and does not plan to influence the company.Johnson & Johnson Innovation - JJDC5.3%Oct 15
All reports
Every insider trade and SEC report we hold for TRex Bio.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Oct 15BoughtAlexandria Venture InvestmentsOct 15 · Traded Oct 13 · 10% owner+13%178,571 @ $14.00$2.5M